Diamond Publications - Search Results

Search Again...

These results only include publications that have been reviewed and processed by Diamond Light Source. To also view papers that have not yet been processed click here.

You can use the folder icon under Actions to collate papers as required. You can then click on View Folder in the left-hand navigation to review and/or download your folder.

One item found (0 items not approved).

Instruments / Technical Area	Publication Details	Published	Actions
B21-High Throughput SAXS	Ellagic acid containing nanostructured lipid carriers for topical application: a preliminary study Supandeep Singh Hallan , Maddalena Sguizzato , Gabriella Pavoni , Anna Baldisserotto , Markus Drechsler , Paolo Mariani , Elisabetta Esposito , Rita Cortesi Molecules 25 DOI: 10.3390/molecules25061449 Open Access Show Abstract ▼ Abstract: Ellagic acid (EA) is a potent antioxidant substance of natural origin characterized by poor biopharmaceutical properties and low solubility in water that limit its use. The aim of the present study was to develop lipid-based nanoparticle formulations able to encapsulate EA for dermal delivery. The EA-loaded nanoparticles were prepared using two different lipid compositions, namely tristearin/tricaprylin (NLC-EA1) and tristearin/labrasol (NLC-EA2). The influence of formulations on size, entrapment efficiency, and stability of EA-loaded nanoparticles was investigated. Cryo-TEM and small-angle X-ray scattering (SAXS) analyses showed that no morphological differences are evident among all the types of loaded and unloaded nanostructured lipid carriers (NLCs). The macroscopic aspect of both NLC-EA1 and NLC-EA2 did not change with time. No difference in size was appreciable between empty and drug-containing NLC, thus the nanoparticle diameter was not affected by the presence of EA and in general no variations of the diameters occurred during this time. The entrapment efficiency of both EA-loaded nanoparticles was almost quantitative. In addition, NLC-EA1 maintained EA stability for almost two months, while NLC-EA2 up to 40 days. FRAP (Ferric reducing ability of plasma) assay showed an antioxidant activity around 60% for both the loaded NLC, as compared to the solution. Although both types of NLC are characterized by some toxicity on HaCaT cells, NLC-EA1 are less cytotoxic than NLC-EA2. Taken together these results demonstrated that the inclusion of EA within NLC could improve the water solubility, allowing for a reduction of the dosage. Moreover, both types of NLC-EA maintained a high antioxidant effect and low toxicity.	Mar 2020

Instruments / Technical Area

Publication Details

Published

Actions

B21-High Throughput SAXS

Ellagic acid containing nanostructured lipid carriers for topical application: a preliminary study

Supandeep Singh Hallan , Maddalena Sguizzato , Gabriella Pavoni , Anna Baldisserotto , Markus Drechsler , Paolo Mariani , Elisabetta Esposito , Rita Cortesi

Molecules 25

DOI: 10.3390/molecules25061449